All they ever do is talk about approvals, but they never start the trials. This has been going on for decades with this company. I used to be a believer, but I have watched this happen for close to 20 years now.
lmao. one more example of prs that mean nothing. this stock is nothing but a bank for max and geert. there is nothing here. never has been and never will be. might as well burn your money over the winter to stay warm. you will get more from it than investing in this company.
IMO - exactly why this company remains trading at under $1/share. Despite the potential - that potential is several years from being a profit generator as a treatement for Head/Neck cancer.
IF (and it remains an if) the HPV-wart treatments look promising in Phase I and Phase II testing - they could actually get into Phase III and be a potential revenue generator before Multikine cancer treatments are finished.
There are risks here. One of the biggest risks is that the time money is left sitting here waiting for the potential uptick in 2015 (or beyond) due to the current Phase III trials long run - that money can be put elsewhere for a more immediate return.
Hey Pappy, did the specialist change it's mind? Can the good Cel-Sci investors/traders put their wet gear away for another day?
You know how much I need the advice of a smart person like you. LOL
...that's valid criticism, but anyone that has ever run a major project knows...something of this magnitude won't be easy and will take time. the only thing u can do is baseline a schedule in the very beginning and try to meet the milestones as quickly as u can (updating the schedule along the way...), but any reasonable person knows things won't happen overnight. so we take the small victories.
"Another moron with a bad attitude!"
I have a bad tude because I dislike clueless people and people that, for some odd reason, find it necessary to post for weeks under one ID and then create another ID to post more or less the same exact BS, ONLY to repeat that process MANY times?
The question that Trium, Hoho, Truthful, Crater, Morty, Dweeby, Bernie, Ralph, LOSER, JOKE will never answer is why he#$%$ is here...ooooooh right, to discuss cel-Sci's red flags, right? LOL
As Geert as stated " this is like watching paint dry". Really? Two more years just for enrollment and then another 3yrs before MK can see market. Five years and that's if everything goes well. No wonder we have a lack of interest from pharmas.
despite ur attempt(s)................there will be no debate between u and i...
...“Never argue with a fool. Onlookers may not be able to tell the difference” –Mark Twain
btw...ur fooling urself if u think any real cvm shareholder on this m/b will heed the advice of a disingenuous hack as urself. most prefer "actual news"...
Hey, Geert, when do you expect enrollment to be completed in the Multikine PhIII?
Until and unless you answer this question, you can add as many Balkan and East European sites as you want and they won't move share price an iota (though wended will be tempted to guess which shell you have the pea under now!).
CEL-SCI RECEIVES GOVERNMENT APPROVAL IN BOSNIA AND HERZEGOVINA TO COMMENCE PHASE III CLINICAL TRIAL OF MULTIKINE IN HEAD AND NECK CANCER
Marks 10th country where Phase III trial is approved to commence accruing patients to the Study and achieving a milestone where half of the planned country approvals for the trial are active
Vienna, VA, December 5, 2013 - Further advancing one of the largest Phase III trials for head and neck cancer in the world, CEL-SCI Corporation (NYSE MKT: CVM) announced today that it has received approval from the Agency for Medicaments and Medical Devices of the government of Bosnia and Herzegovina to begin enrollment of subjects into the Phase III Head and Neck Cancer clinical trial of its investigational cancer immunotherapy treatment Multikine* (Leukocyte Interleukin, Injection). Bosnia and Herzegovina is the 10th country into which CEL-SCI has now expanded its global Phase III trial. This also marks the Company's milestone in receiving approval to commence accrual in one-half the number of countries in the currently planned expansion of the study. The trial is expected to expand into a total of approximately 100 clinical centers in 20 countries. CEL-SCI expects to enroll approximately 30 patients in Bosnia and Herzegovina through three clinical centers.
Multikine is the first immunotherapeutic agent being developed as a potential first-line treatment for advanced primary head and neck cancer. If it were to be approved by regulatory agencies (e.g. FDA) for use following completion of CEL-SCI's clinical development program, Multikine would become an additional and different kind of therapy in the fight against cancer: one that aims to employ our body's natural ability to fight tumors.
CEL-SCI is currently accelerating enrollment in its Phase III clinical trial for Multikine by adding a large number of clinical centers. In addition to these centers, the trial also benefits from clinical centers in CEL-SCI's partners' territories, Teva Pharmaceuticals in Israel and Orient Europharma in Taiwan.
"We are pleased with the accelerating pace at which new clinical centers and countries, which will participate in our study, are being added. From this we expect to see a fast pick-up in the number of patients enrolled in the study. We are aiming to complete enrollments of subjects in the second half of 2015. CEL-SCI offers a potential first-line approach to cancer treatment that employs the body's own immune system, before the current standard of care, which includes surgery plus radiation therapy or surgery and combined radiochemotherapy, is used," stated CEL-SCI CEO Geert Kersten.
The Multikine Phase III study is enrolling patients with advanced primary, not yet treated, head and neck cancer. The objective of the study is to demonstrate a statistically significant, 10% improvement in overall survival of enrolled patients who are treated with Multikine plus Standard of Care (SOC) vs. subjects who are treated with SOC only. Multikine is intended to create an anti-tumor immune response to reduce local / regional tumor recurrence and thereby increase the survival rate of these patients.
Another bit of idiocy from the self-proclaimed world's greatest trader: you made a profit on an earlier trade in X so it's OK to lose money on a second trade in X!
Losing money is losing money, and even a raw beginner to the world of investing should understand that each subsequent investment decision should be made on its own merits alone, not some idiotic notion such as your 'I made some money, so now I can afford to lose it!'
The point, which your feeble mind can't seem to grasp, is that an investment in CVM has zero prospect of generating a return over the long term since Multikine has no chance to succeed in its trial, LEAPS is a case study in complete futility, cold fill is pure nonsense, and Geert is nothing but a self-serving con man running an onbvious scam!
That means that trading CVM is akin to abetting Geert's shell game, and playing
alongside the huckster hoping to catch the right moves of the pea under the shell is pure randomness.
But that seems to be the ultimate skill of the self-proclaimed world's greatest trader, teking random walks and calling them planned itineraries after they just happen actually to lead somewhere!
...giving him that much attention. He has already burned up the key board with 3 posts with nothing but you as the subject in each one... Pappy, you should be commended on your talents of helping the mentally challenged enjoy life to it's fullest.... What a wonderful world this would be if everyone just followed your lead in yet another of your many endeavors to make everyone feel appreciated... Thank you Pappy, thank you...!
I'm really not, but have I mentioned that I find it VERY annoying that you say "Follow my lead" when the rest of the planet already knows?
On a serious note, do you really think you know more than others that have been playing the market for more than 4-5 years? CVM was below 80 cents for the first time in a while, so you felt that was a good time to say that the specialist is done with CVM? Really?
You can say whatever you want, but when someone ask you what you mean by that, and what will happen next, DON'T mistake that for asking for "Advice"!
I'll ask you again...what happens next:
Do we drop 6-7 cents in the next 1-2 weeks?
Do we drop 1-2 cents and linger there for the next 4-5 weeks?
Do we stay at .79 for the next 5 months?
Can't you understand that a guy that says, "Follow my lead" should know the answer to these questions? People can't follow your lead when you're lagging behind!
Oh right. we went sub 80 cents for the first time in a while, so you decided post a vague comment about the specialist being done with CVM...is that all you got, Ole great One???